The effects of platinum chemotherapy on essential trace elements

European Journal of Cancer Care

Volumn 5, Issue 2, 1996, Pages 122-126

  Pezonaga, Idoya ^a   Taylor, Andrew ^c   Dobrota, Miloslav ^b  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c NONE

Author keywords

Cancer; Copper; Kidney; Magnesium; Platinum; Zinc

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; TRACE ELEMENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NEOPLASM;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; CISPLATIN; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; TRACE ELEMENTS;

EID: 0030160594     PISSN: 09615423     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2354.1996.tb00219.x     Document Type: Article

References (25)

1. Baldew G.S., McVie J.G., Van der Valk M.A., Los G., de Goej J.M. & Vermeulen N.P.E. (1990) Selective reduction of cis-diaminedichloroplatinum(II) nephrotoxicity by Ebselen. Cancer Research, 50, 7031-7036.
2. Bell D.R., Woods R.L. & Levi J.A. (1985) Cis-diammininedichloroplatinum-induced hypomagnesaemia and renal Mg wasting. European Journal of Cancer and Clinical Oncology, 21, 287-290.
3. Bhattacharya J., Chakraborti A.S., Basu A. & Mitra S. (1982) Serum copper levels in leukaemia and lymphoma. IRCS Medical Science, 10, 759-760.
4. Collecchi P., Cafiero F., Vecchio C., Gipponi M., Bozzinio A.M., Percivale P.L. & Esposito M. (1987) Erythrocyte, plasma and serum levels of zinc and copper in normal subjects and in patients with rectal cancer. Medical Scientific Research, 15, 1073-1074.
5. Cousins R.J. & Leinart A.S. (1988) Tissue specific regulation of zinc metabolism and metaflothionein genes by interleukin 1. FASEB Journal, 2, 2884-2890.
6. DeWoskin R.S. & Riviere J.E. (1992) Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna. Toxicology and Applied Pharmacology, 112, 182-189.
7. Fabris C., Farini R., Del Favero G., Gurrieri G., Piccoli A., Sturniolo G.C., Panucci A. & Naccarato R. (1985) Copper, zinc and copper/zinc ration in chronic pancreatitis and pancreatic cancer. Clinical Biochemistry, 18, 373-375.
8. Giaccone G., Donadio M., Ferrati P., Ciuffreda L., Bagatella M., Gaddi M. & Calciati A. (1985) Disorders of serum electrolytes and renal function in patients treated with cis-platinum on an outpatient basis. European Journal of Cancer and Clinical Oncology, 21, 433-437.
9. Harrap K.R. (1984) Platinum coordination complexes in cancer chemotherapy. Platinum Metals Review, 28, 14-19.
10. Haswell S.J. (1991) Atomic Absorption Spectrometry Theory, Design and Applications. Elsevier, Amsterdam.
11. Hrgovcic M., Tessmer C.T., Thomas F.B., Fuller L.M., Gamble J.F. & Schullenberger C.C. (1973) Significance of serum copper levels in adult patients with Hodgkin's disease. Cancer, 31, 1337-1345.
12. Lane H.W. & Medina D. (1983) Selenium concentration and glutathione peroxidase activity in normal and neoplastic development of the mouse mammary gland. Cancer Research, 43, 1558-1561.
13. Mason R.W., Edwards I.R. & McLaren S.J. (1984) Interaction of platinum with metallothionein-like ligands in the rat kidney after administration of cis-dichlorodiammine platinum D. Chemical-Biological Interactions, 49, 165-176.
14. Mason R.W. & Edwards I.R. (1985a) Cisplatin-induced alteration of the copper and zinc content of the rat kidney. Biochemical Pharmacology, 14, 2575-2577.
15. Mason R.W. & Edwards I.R. (1985b) Studies on the copper and zinc content of the rat kidney after treatment with cisplatin. Toxicology, 37, 267-274.
16. Schilsky R.L. & Anderson T. (1979) Hypomagnesaemia and renal magnesium wasting in patients receiving cisplatin. Annals of Internal Medicine, 90, 929-931.
17. Schrauzer G.N. (1979) Trace elements in carcinogenesis. In: Draper H.H. (ed.) Advances in Nutritional Research, 2, 219-244. Plenum, New York.
18. Schroeder J.S. & Cousins R.J. (1990) Interleukin 6 regulates metallothionein gene expression and zinc metabolism in hepatocyte monolayer cultures. Proceedings of the National Academy of Sciences of USA, 87, 3137-3141.
19. Scuderi P. (1990) Differential effects of copper and zinc on human peripheral blood monocyte cytokine secretion. Cellular Immunology, 126, 391-406.
20. Sengas J.B., Goumas P.D., Papadimatos N.G. & Helidonis E.S. (1987) Zinc and copper in cancer of the larynx. Medical Scientific Research, 15, 793-794.
21. Sharma R.P. (1985) Interactions of cis-platinum with cellular zinc and copper in rat liver and kidney tissues. Pharmacological Research Communications, 17, 197-206.
22. Taylor A. (1985) Therapeutic uses of trace elements. In: Taylor A. (ed.) Clinics in Endocrinology and Metabolism, 14, 703-724. W.B. Saunders, Eastbourne.
23. Warren R.L., Jellife A.M., Watson J.V. & Hobbs C.B. (1969) Prolonged observations in the serum copper in Hodgkin's disease. Clinical Radiology, 20, 247-256.
24. Willett W.C., Morris J.S., Pressel S., Taylor J.O., Polk B.F., Stampfer M.J., Rosner B., Schneider K. & Hames C.G. (1983) Prediagnostic serum selenium and risk of cancer. Lancet, ii, 130-134.
25. Zumkley H., Bertram H.P., Preusser P., Kellinghaus H., Straub C. & Vetter H. (1982) Renal excretion of magnesium and trace elements during cisplatin treatment. Clinical Nephrology, 17, 254-257.